64951-07-1

基本信息
ETHYL IMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLATE
ethyl imidazo[1,2-a]pyrimidine-7-carboxylate
ETHYL IMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLATE ISO 9001:2015 REACH
物理化学性质
制备方法

109-12-6

70-23-5
![咪唑并[1,2-A]嘧啶-3-羧酸乙酯](/CAS/GIF/64951-07-1.gif)
64951-07-1
![咪唑[1,2-A]嘧啶-2-甲酸乙酯](/CAS/GIF/64951-06-0.gif)
64951-06-0
以2-氨基嘧啶(5克,52.6毫摩尔)和3-溴丙酮酸乙酯(90%纯度,7.35毫升,52.6毫摩尔)为原料,溶于乙醇(80毫升)中,反应混合物加热至75℃反应16小时。反应完成后,减压浓缩反应混合物,用二氯甲烷(CH2Cl2)和饱和碳酸氢钠(NaHCO3)水溶液稀释。有机层用饱和NaHCO3水溶液洗涤两次,水层用CH2Cl2萃取三次。合并有机层,用无水硫酸镁(MgSO4)干燥后减压浓缩。得到的棕色油状物悬浮于冷的CH2Cl2中,过滤,滤饼用冷CH2Cl2洗涤,得到咪唑并[1,2-a]嘧啶-2-羧酸乙酯(3克,30%收率),为浅黄色油状物。母液中含有咪唑并[1,2-a]嘧啶-2-羧酸乙酯和咪唑并[1,2-a]嘧啶-3-羧酸乙酯的混合物(6克,60%收率),呈粘稠黑色油状。该黑色油状物首先通过硅胶柱色谱法纯化,然后从乙酸乙酯(EtOAc)中重结晶,得到纯的咪唑并[1,2-a]嘧啶-3-羧酸乙酯(2克,20%收率)。 对于2-异构体:1H NMR(500MHz,CDCl3)δ8.69(dd,J = 2.2,6.6Hz,1H),8.67(dd,J = 2.2,4.4Hz,1H),8.22(s,1H),7.01(dd,J = 3.9,6.6Hz,1H),4.46(q,J = 7.2Hz,2H),1.43(t,J = 7.2Hz,3H)。13C NMR(500MHz,CDCl3)δ162.8,152.2,147.8,137.7,134.4,115.3,110.0,61.2,14.2。HPLC-MS Phenomenex LUNA C-18 4.6 x 50 mm,0至100%B,4分钟,1分钟保持时间,A = 90%水,10%甲醇,0.1%TFA,B = 10%水,90%甲醇,0.1%TFA,RT = 0.99分钟,95%均匀度指数。LCMS:分析。计算。C9H9N3O2的测定结果191.07实测值:192.13(M + H)+。 对于3-异构体:HPLC Phenomenex LUNA C-18 4.6 x 50 mm,0至100%B,4分钟,1分钟保持时间,A = 90%水,10%甲醇,0.1%TFA,B = 10%水,90%甲醇,0.1%TFA,RT = 1.39分钟,100%同质性指数。LCMS:计算。C9H9N3O2的测定结果191.07实测值:192.19(M + H)+。
参考文献:
[1] Patent: WO2006/71752, 2006, A1. Location in patent: Page/Page column 83
[2] European Journal of Medicinal Chemistry, 1994, vol. 29, # 4, p. 279 - 286
[3] European Journal of Medicinal Chemistry, 1991, vol. 26, # 1, p. 13 - 18
[4] Journal of Medicinal Chemistry, 2010, vol. 53, # 15, p. 5620 - 5628
[5] Patent: WO2018/11628, 2018, A1. Location in patent: Paragraph 00266